Brinckerhoff Comments on Proposed Legislation Aimed at Curbing Drug Prices
01 January 2020
Partner Courtenay Brinckerhoff was quoted in a Law360 article, “Patent Legislation To Watch In 2020,” about a slew of pending bills aimed at curbing drug prices.
Brinckerhoff said the bills that have been proposed to date appear to need work and may not have their intended effect. “I don’t necessarily think they would achieve the intended purpose and would have a lot of unintended consequences,” she said. “Once people who understand the nitty gritty details of the patent system look at them, some of those will fall apart.”
People
Related News
08 May 2024
In the News
Benjamin Dryden on Noncompete Ban – Expect Trade Secret Litigation Increase in ‘Volume and Nastiness’
Foley & Lardner LLP partner Benjamin Dryden offered insight on the specific impact to the manufacturing sector of the U.S. Federal Trade Commission’s (FTC) recently issued final rule banning noncompete agreements
08 May 2024
In the News
Foley Real Estate, Hospitality Transactions Highlighted in Golf Inc.
Foley & Lardner LLP served as legal advisor on two of Golf Inc.’s Top 10 Sales of 2023.
08 May 2024
In the News
Kyle Faget Assesses FDA Rule Regulating Lab-Developed Tests, Potential Challenges
Foley & Lardner LLP partner Kyle Faget offers insight on potential challenges to the U.S. Food and Drug Administration’s (FDA) final rule regulating lab-developed tests (LDTs)